These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 19394248)
1. Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Costa N; Paramanathan S; Mac Donald D; Wierzbicki AS; Hampson G Cytokine; 2009 Jun; 46(3):376-81. PubMed ID: 19394248 [TBL] [Abstract][Full Text] [Related]
2. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500 [TBL] [Abstract][Full Text] [Related]
3. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192 [TBL] [Abstract][Full Text] [Related]
4. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM Menopause; 2007; 14(5):913-8. PubMed ID: 17667143 [TBL] [Abstract][Full Text] [Related]
5. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women. Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902 [TBL] [Abstract][Full Text] [Related]
6. Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women. Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Zintzaras E; Tsatsoulis A Maturitas; 2006 Mar; 53(4):380-5. PubMed ID: 16125346 [TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis. Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820 [TBL] [Abstract][Full Text] [Related]
8. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419 [TBL] [Abstract][Full Text] [Related]
9. Associations of genetic lactase non-persistence and sex with bone loss in young adulthood. Laaksonen MM; Impivaara O; Sievänen H; Viikari JS; Lehtimäki TJ; Lamberg-Allardt CJ; Kärkkäinen MU; Välimäki M; Heikkinen J; Kröger LM; Kröger HP; Jurvelin JS; Kähönen MA; Raitakari OT; Bone; 2009 May; 44(5):1003-9. PubMed ID: 19168163 [TBL] [Abstract][Full Text] [Related]
11. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Arko B; Prezelj J; Kocijancic A; Komel R; Marc J Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970 [TBL] [Abstract][Full Text] [Related]
12. [Study of the impact of candidate genes on bone mineral density in postmenopausal women]. Zhao HY; Liu JM; Ning G; Zhang LZ; Song HD; Chen Y; Jiang L; Dai M; Xu MY; Chen JL Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):803-7. PubMed ID: 16412323 [TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Macdonald HM; McGuigan FE; Fraser WD; New SA; Ralston SH; Reid DM Bone; 2004 Oct; 35(4):957-64. PubMed ID: 15454103 [TBL] [Abstract][Full Text] [Related]
14. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083 [TBL] [Abstract][Full Text] [Related]
15. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z Menopause; 2009; 16(5):950-5. PubMed ID: 19387415 [TBL] [Abstract][Full Text] [Related]
16. Plasma vascular endothelial growth factor levels are similar in subjects with and without osteoporosis. Cebi H; Akşahin E; Yüksel HY; Celebi L; Aktekin CN; Hapa O; Muratli HH; Biçimoğlu A Eklem Hastalik Cerrahisi; 2010 Aug; 21(2):91-7. PubMed ID: 20632925 [TBL] [Abstract][Full Text] [Related]
17. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women. Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995 [TBL] [Abstract][Full Text] [Related]
18. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women. Malacara JM; Pérez-Luque EL; Martínez-Garza S; Sánchez-Marín FJ Maturitas; 2004 Oct; 49(2):163-9. PubMed ID: 15474761 [TBL] [Abstract][Full Text] [Related]
19. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population. Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764 [TBL] [Abstract][Full Text] [Related]
20. The positive effect of dietary vitamin D intake on bone mineral density in men is modulated by the polyadenosine repeat polymorphism of the vitamin D receptor. Michaëlsson K; Wolk A; Jacobsson A; Kindmark A; Grundberg E; Stiger F; Mallmin H; Ljunghall S; Melhus H Bone; 2006 Dec; 39(6):1343-51. PubMed ID: 16860619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]